Why chemotherapy is a primary weapon against spreading testicular cancer
In short: While not every patient requires it, chemotherapy is a highly effective tool for treating specific types of testicular cancer. When tumors move beyond the testicle into the chest or abdominal cavity, medical oncologists often turn to these medication cycles to aim for a complete cure.
Chemotherapy involves administering medications through intravenous lines to target and destroy cancer cells. In the context of testicular cancer, its application depends heavily on the specific type of tumor and its progression. For instance, non-seminomatous tumors that have spread to the abdominal region are common candidates for this treatment. Medical oncologists typically deliver these medications over several cycles, with the primary objective being the total cure of the disease. Specialists administer these drugs via IV infusions to kill malignant cells. This approach is particularly vital for non-seminomatous varieties.
The decision to use chemotherapy is not universal. For some, doctors may recommend surveillance—a process of continuous monitoring to ensure the cancer does not develop elsewhere. Others may undergo surgery, such as a retroperitoneal lymph node dissection, which involves removing lymph nodes in the abdominal area to confirm the absence of cancer. The choice between surveillance, surgery, or chemotherapy depends on the individual's specific diagnosis and the risk profile of the tumor. Surveillance involves watching the patient closely to detect any new developments. This helps determine if further intervention is necessary.
Even when the cancer remains localized within the testicle, chemotherapy may still be offered. Doctors look for specific aggressive features to determine this risk. One such feature is lymphovascular invasion, which suggests the possibility of microscopic disease elsewhere in the body. Another indicator is the presence of embryonal carcinoma, a specific variant of non-seminomatous tumors. In these cases, the potential for aggressive behavior justifies considering chemotherapy even without visible spread to the abdominal cavity or chest. Certain aggressive characteristics within the testicle can trigger this recommendation. These indicators help identify risks of undetected microscopic spread.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Chemotherapy | Testicular Cancer
To cite this card, link to https://intellectplus.co.uk/app/society-chemotherapy-testicular-cancer.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Society · Latest · A–Z · All topics
